ctrl K

Vera Therapeutics Inc. (VERA)

NASDAQ: VERA · Real-Time Price · USD

23.70

0.33 (1.41%)

At close: May 01, 2025, 3:59 PM

Vera Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	1.86M	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	-846K	176K	251K	509K
Gross Profit	n/a	1.86M	846K	-176K	-251K	-509K
Operating Income	-167.17M	-102.01M	-90.9M	-34.4M	-52.24M	-11.96M
Interest Income	20.71M	4.19M	1.75M	15K	8K	159K
Pretax Income	-152.15M	-95.99M	-89.06M	-32.61M	-53.41M	-11.85M
Net Income	-152.15M	-95.99M	-89.06M	-32.61M	-53.41M	-11.85M
Selling & General & Admin	41M	23.79M	21.91M	11.92M	4.04M	4.41M
Research & Development	126.17M	78.22M	68.99M	22.48M	45.21M	7.29M
Other Expenses	n/a	n/a	1.85M	1.79M	-1.08M	n/a
Operating Expenses	167.17M	102.01M	90.9M	34.4M	49.24M	11.7M
Interest Expense	-7.63M	n/a	992K	20K	166K	51K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	102.01M	90.9M	34.4M	49.24M	11.7M
Income Tax Expense	-1K	1K	1K	1K	1K	1K
Shares Outstanding (Basic)	55.33M	42.71M	26.57M	21.28M	3.71M	3.42M
Shares Outstanding (Diluted)	55.33M	42.71M	26.57M	21.28M	3.71M	3.42M
EPS (Basic)	-2.75	-2.25	-3.35	-1.53	-14.4	-3.46
EPS (Diluted)	-2.75	-2.25	-3.35	-1.53	-14.4	-3.46
EBITDA	-167.17M	-102.01M	-90.9M	-34.23M	-52.99M	-11.19M
EBIT	-159.77M	-102.01M	-88.06M	-34.4M	-53.25M	-11.8M
Depreciation & Amortization	-7.4M	n/a	-846K	176K	251K	509K